OPKOPKO Health, Inc.

$894M

Q2 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$314M-12.0% YoY

Gross Profit

$139M44.2% margin

Operating Income

-$26M-8.2% margin

Net Income

-$18M-5.6% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+6.1%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$30M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$662M

Stockholders' Equity

$2.1B

Cash & Equivalents

$131M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$314M	$357M	-12.0%
Gross Profit	$139M	$204M	-31.8%
Operating Income	-$26M	$28M	-191.4%
Net Income	-$18M	$16M	-212.8%

Revenue Segments

Rayaldee

$4M100%

Geographic Segments

UNITED STATES

$267M85%

IRELAND

$22M7%

CHILE

$12M4%

ISRAEL

$8M2%

SPAIN

$5M2%

MEXICO

$724,0000%

Other Countries

$31,0000%

OPK Q2 2017 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena